A Phase 3 Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High-Risk, Early-Stage Endometrial Cancer: A Gynecology Oncology Group Study

被引：22
|
作者：
Randall, M. [1 ]
Filiaci, V. [2 ]
McMeekin, D. [3 ]
Yashar, C. M. [4 ]
Mannel, R. [3 ]
Salani, R. [5 ]
DiSilvestro, P. [6 ]
Burke, J. [7 ]
Rutherford, T. [8 ]
Spirtos, N. [9 ]
Cho, J. [10 ]
Kim, J. [11 ,12 ]
Anderson, P. [13 ]
Brewster, W. [14 ]
Small, W. [15 ]
Carney, M. [16 ]
Aghajanian, C. [17 ]
Miller, D. S. [18 ]
机构：
[1] Univ Kentucky, Lexington, KY USA
[2] NRG Oncol Stat & Data Management Ctr, Buffalo, NY USA
[3] Univ Oklahoma, Oklahoma City, OK USA
[4] Univ Calif San Diego, San Diego, CA 92103 USA
[5] Ohio State Univ, Columbus, OH 43210 USA
[6] Brown Univ, Providence, RI 02912 USA
[7] Mem Univ, Savannah, GA USA
[8] Yale Gynecol Oncol, New Haven, CT USA
[9] Womens Canc Ctr Nevada, Las Vegas, NV USA
[10] Univ Hawaii, Honolulu, HI 96822 USA
[11] Seoul Natl Univ, Seoul, South Korea
[12] Korean Gynecol Oncol Grp, Seoul, South Korea
[13] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[14] Univ N Carolina, Chapel Hill, NC USA
[15] Loyola Univ Med Ctr, Maywood, IL 60153 USA
[16] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA
[17] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[18] Univ Texas Southwestern, Dallas, TX USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 05期
关键词：
D O I：
10.1016/j.ijrobp.2017.09.008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA-1
引用
收藏
页码：1313 / 1313
页数：1
相关论文
共 50 条
  • [41] Pathologic Response After Neoadjuvant Carboplatin and Weekly Paclitaxel for Early-Stage Lung Cancer A Brown University Oncology Group Phase II Study
    Ahmed, Shair
    Birnbaum, Ariel E.
    Safran, Howard P.
    Dipetrillo, Thomas A.
    Aswad, Bassam I.
    Ready, Neal E.
    Ng, Thomas
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (08) : 1432 - 1434
  • [42] Survival after recurrence in early-stage high-risk epithelial ovarian cancer: A Gynecologic Oncology Group study
    Chan, John K.
    Tian, Chunqiao
    Teoh, Deanna
    Monk, Bradley J.
    Herzog, Thomas
    Kapp, Daniel S.
    Bell, Jeffrey
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 307 - 311
  • [43] A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902
    Rosenthal, Seth A.
    Hunt, Daniel
    Sartor, Oliver
    Pienta, Kenneth J.
    Gomella, Leonard
    Grignon, David
    Rajan, Raghu
    Kerlin, Kevin J.
    Jones, Christopher U.
    Dobelbower, Michael
    Shipley, William U.
    Zeitzer, Kenneth
    Hamstra, Daniel A.
    Donavanik, Viroon
    Rotman, Marvin
    Hartford, Alan C.
    Michalski, Jeffrey
    Seider, Michael
    Kim, Harold
    Kuban, Deborah A.
    Moughan, Jennifer
    Sandler, Howard
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (02): : 294 - 302
  • [44] Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
    Ozols, RF
    Bundy, BN
    Greer, BE
    Fowler, JM
    Clarke-Pearson, D
    Burger, RA
    Mannel, RS
    DeGeest, K
    Hartenbach, EM
    Baergen, R
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) : 3194 - 3200
  • [45] A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study
    Bae-Jump, Victoria L.
    Sill, Michael W.
    Gehrig, Paola A.
    Merker, Jason D.
    Corcoran, David L.
    Pfefferle, Adam D.
    Hayward, Michele C.
    Walker, Joan L.
    Hagemann, Andrea R.
    Waggoner, Steven E.
    O'Cearbhaill, Roisin E.
    Mcdonald, Megan E.
    Edelson, Mitchell I.
    Disilvestro, Paul A.
    Mcnally, Amy L.
    Fleury, Aimee
    Littell, Ramey D.
    Ueland, Frederick R.
    Lankes, Heather A.
    Aghajanian, Carol
    GYNECOLOGIC ONCOLOGY, 2025, 195 : 66 - 74
  • [46] A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG Oncology/GOG study
    Bae-Jump, V. L.
    Sill, M.
    Gehrig, P. A.
    Moxley, K.
    Hagemann, A. R.
    Waggoner, S. E.
    O'Cearbhaill, R. E.
    McDonald, M.
    DiSilvestro, P. A.
    Sperduto, P.
    Aghajanian, C.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 7 - 7
  • [47] Chemoradiation With Paclitaxel and Carboplatin in High-Risk Cervical Cancer Patients After Radical Hysterectomy: A Korean Gynecologic Oncology Group Study
    Lee, Taek Sang
    Kang, Soon Beom
    Kim, Young Tak
    Park, Byung Joo
    Kim, Yong Man
    Lee, Jong Min
    Kim, Seok Mo
    Kim, Young Tae
    Kim, Jae Hoon
    Kim, Kyung Tai
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (02): : 304 - 310
  • [48] Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2- breast cancer: a randomized phase 3 trial
    Cardoso, Fatima
    O'Shaughnessy, Joyce
    Liu, Zhenzhen
    Mcarthur, Heather
    Schmid, Peter
    Cortes, Javier
    Harbeck, Nadia
    Telli, Melinda L.
    Cescon, David W.
    Fasching, Peter A.
    Shao, Zhimin
    Loirat, Delphine
    Park, Yeon Hee
    Fernandez, Manuel Gonzalez
    Rubovszky, Gabor
    Spring, Laura
    Im, Seock-Ah
    Hui, Rina
    Takano, Toshimi
    Andre, Fabrice
    Yasojima, Hiroyuki
    Ding, Yu
    Jia, Liyi
    Karantza, Vassiliki
    Tryfonidis, Konstantinos
    Bardia, Aditya
    NATURE MEDICINE, 2025, 31 (02) : 442 - 448
  • [49] Phase II study of paclitaxel (TXL), doxorubicin (ADM) and carboplatin (CBDCA) combination therapy (TAC) in patients with high-risk and recurrent endometrial cancer.
    Sugiyama, T
    Omi, H
    Kigawa, J
    Hatae, M
    Suzuki, M
    Tsuda, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 475S - 475S
  • [50] The role of radical surgery followed by adjuvant therapy for high-risk early-stage cervical carcinoma patients with pelvic lymph node metastasis
    Lin, H
    Changchien, CC
    Huang, EY
    Eng, HL
    Huang, CC
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2000, 93 (01): : 85 - 90
12345